Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Cancer Management and Research Volume 3, 2011 - Issue

Submit an article Journal homepage

Open access

188

Views

CrossRef citations to date

Altmetric

Review

Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies

Gina M Mantia-Smaldone1 Division of Gynecologic Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USACorrespondence[email protected]

Robert P Edwards2 Division of Gynecologic Oncology, Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Anda M Vlad3 Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee-Womens Research Institute, Pittsburgh PA, USA

Pages 25-38 | Published online: 30 Sep 2022

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (4)

Erin G. Hartnett, Julia Knight, Mackenzy Radolec, Ronald J. Buckanovich, Robert P. Edwards & Anda M. Vlad. (2020) Immunotherapy Advances for Epithelial Ovarian Cancer. Cancers 12:12, pages 3733.
Crossref

Annamaria Salvati, Valerio Gigantino, Giovanni Nassa, Giorgio Giurato, Elena Alexandrova, Francesca Rizzo, Roberta Tarallo & Alessandro Weisz. (2019) The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells. Cancers 11:11, pages 1720.
Crossref

Meghan Leary, Sarah Heerboth, Karolina Lapinska & Sibaji Sarkar. (2018) Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy. Cancers 10:12, pages 483.
Crossref

R E Kast. (2012) Epithelial ovarian cancer: A feasible plan for adjunctive treatment using simultaneous acyclovir, ambrisentan, captopril, disulfiram, fluvoxamine-augmented ramelteon, icatibant, imiquimod peritoneal lavage, and plerixafor. journal of Cancer Therapeutics and Research 1:1, pages 2.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references